Neueste Veröffentlichungen

• Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia: letters to the editor
  Article (Journal), Editorial, Online Resource
• Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib
  Article (Journal), Online Resource
• Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question
  Article (Journal), Online Resource
• Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
  Article (Journal), Online Resource
• Post-induction treatment for acute myeloid leukemia: something change?
  Article (Journal), Online Resource

Alle anzeigen (10)

Co-Autoren

• Schlenk, Richard Friedrich
• Müller-Tidow, Carsten
• Görner, Martin
• Kieser, Meinhard
• Kratzmann, Markus

Alle anzeigen (71)

Publikationsjahre

Publikationstypen